Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Friedlander L"'
Autor:
Gurakar A; Central Blood Bank of Pittsburgh, PA, USA., Fagiuoli S, Faruki H, De Maria N, Balkan M, Van Thiel DH, Friedlander L
Publikováno v:
Hepatology (Baltimore, Md.) [Hepatology] 1995 Oct; Vol. 22 (4 Pt 1), pp. 1109-12.
A total of 41 patients with chronic hepatitis C virus (HCV) defined as abnormal liver injury test results for 6 months or more and HCV RNA positivity in plasma were studied to determine if the liver might not be the only focus of HCV infection in ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::de235047eda57136284751cf5c2c90cb
http://hdl.handle.net/10281/353719
http://hdl.handle.net/10281/353719
Objective: To determine whether individuals with concurrent active psychiatric disease and chronic hepatitis C virus (HCV) can be treated safely and effectively with interferon-alpha. Design: Prospective, open label study. Setting: Tertiary referral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::58b26c7ed63c259c83c413b075add457
http://hdl.handle.net/10281/353100
http://hdl.handle.net/10281/353100
Interferon alpha (IFN) is the only Food and Drug Administration (FDA)-approved therapy available for the treatment of chronic hepatitis C. The ideal dose and frequency of IFN administration that produces the greatest number of patient responders with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c86e3de439220f3d017992869d097d2b
http://hdl.handle.net/10281/353900
http://hdl.handle.net/10281/353900